Enabled by a proprietary production technology, our patented submicron particles of pure drug are suspended at time of use and targeted directly to the site of disease where they become entrapped continuously releasing drug molecules as they dissolve.


Patented submicron particles of pure drug are locally delivered directly to the site of disease.

Particles versus

The particles become entrapped at the disease site whereas drug in solution leaks out by simple diffusion.

Enabling Production Technology

A proprietary production technology forms uniform, static-free pure drug particles that are simply suspended just prior to local administration.

IP Portfolio

A composition of matter patent protects the regulatory specifications for the particles forming the foundation of an extensive global intellectual property portfolio.